Cita APA

Skinningsrud, B., Lie, B. A., Husebye, E. S., Kvien, T. K., Førre, Ø., Flatø, B., . . . Undlien, D. E. (2010). A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis. BMJ Group.

Chicago Style Citation

Skinningsrud, Beate, et al. A CLEC16A Variant Confers Risk for Juvenile Idiopathic Arthritis and Anti-cyclic Citrullinated Peptide Antibody Negative Rheumatoid Arthritis. BMJ Group, 2010.

Cita MLA

Skinningsrud, Beate, et al. A CLEC16A Variant Confers Risk for Juvenile Idiopathic Arthritis and Anti-cyclic Citrullinated Peptide Antibody Negative Rheumatoid Arthritis. BMJ Group, 2010.